- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04247477
Comparison of Different PEEP Titration Strategies Using Electrical Impedance Tomography in Patients With ARDS (DELTA)
July 29, 2022 updated by: University Hospital, Angers
Comparison of Different Positive End-expiratory Pressure Titration Strategies Using ELectrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrome : the DELTA Physiological Study
The aim of the this study is to assess the short term physiological effects of 3 ventilation strategies for adult patients with ARDS admitted to intensive care unit.
Two of those strategies are based on electrical impedance tomography (EIT) monitoring.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Angers, France, 49100
- CHU Angers
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients with moderate to severe ARDS, defined by the Berlin consensus, at 12 to 48h from diagnosis
- PaO2/FiO2 ratio < 150 mmHg
- Patient affiliated to or beneficiary of a health care plan
- Consent obtained from patient's SDM
Exclusion Criteria:
- Pneumothorax
- Contraindication to the insertion of a nasogastric tube with an esophageal balloon
- Contraindication to the use of Electrical impedance tomography
- Pregnancy, lactating or parturient woman
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: A-B-A-C
Four consecutive steps (45 min per step) are tested in the following order: Peep titration strategy according to Express method (A) - Peep titration strategy according to overdistension and collapse estimation (B) - Peep titration strategy according to Express method (A) - Peep titration strategy according to estimation of lung inhomogeneity (C)
|
Patients are ventilated in randomized order with three different ventilation strategies (A,B and C)
|
|
Experimental: A-C-A-B
Four consecutive steps (45 min per step) are tested in the following order: Peep titration strategy according to Express method (A) - Peep titration strategy according to estimation of lung inhomogeneity (C) - Peep titration strategy according to Express method (A) - Peep titration strategy according to overdistension and collapse estimation (B)
|
Patients are ventilated in randomized order with three different ventilation strategies (A,B and C)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in PaO2 (mmHg)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance!
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in PaCO2 (mmHg)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
|
Plateau pressure (cmH2O)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
|
Positive end expiratory pressure (cmH2O)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
|
Expiratory and inspiratory transpulmonary pressure (cmH2O)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
|
Regional ventilation distribution (%)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
|
Center of ventilation (%)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
|
Overdistension and collapsus (%)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
|
Global and regional end expiratory lung impedance changes (IU)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
|
End expiratory lung volume (mL)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
|
Blood pressure (mmHg)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
|
Heart rate (bpm)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
|
Cardiac output (L/min)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
As it is a physiological study, all the outcomes will be analyzed with the same importance
|
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 22, 2020
Primary Completion (Actual)
April 8, 2021
Study Completion (Actual)
April 8, 2021
Study Registration Dates
First Submitted
January 21, 2020
First Submitted That Met QC Criteria
January 27, 2020
First Posted (Actual)
January 30, 2020
Study Record Updates
Last Update Posted (Actual)
August 2, 2022
Last Update Submitted That Met QC Criteria
July 29, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 49RC19_0249
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Lung Injury
-
People's Hospital of Guangxi Zhuang Autonomous...CompletedAcute Lung Injury(ALI)China
-
Shanghai University of Traditional Chinese MedicineRecruitingAcute Respiratory Distress Syndrome (ARDS) | Acute Lung Injury(ALI) | Sepsis Related Acute Lung Injury/Acute Respiratory Distress SyndromeChina
-
University of CalgaryNot yet recruitingARDS (Acute Respiratory Distress Syndrome)
-
Ain Shams UniversityEnrolling by invitationARDS (Acute Respiratory Distress Syndrome)Egypt
-
Ain Shams UniversityCompleted
-
Centre Hospitalier Saint Joseph Saint Luc de LyonRecruitingARDS (Acute Respiratory Distress Syndrome)France
-
Ming ZhongNot yet recruitingARDS (Acute Respiratory Distress Syndrome)China
-
Peking Union Medical College HospitalNot yet recruiting
-
Yongtao SunNot yet recruitingAcute Lung InjuryChina
-
Centre Integre Universitaire de Sante et Services...Not yet recruitingARDS (Acute Respiratory Distress Syndrome) | Invasive Mechanical Ventilation | Patient-Self Inflicted Lung InjuryCanada
Clinical Trials on Ventilation strategy
-
Oslo University HospitalRigshospitalet, Denmark; Aalborg University HospitalNot yet recruitingAcute Respiratory Distress Syndrome (ARDS) | Acute Hypoxemic Respiratory Failure
-
Affiliated Hospital of Nantong UniversityCompletedTumor MicroenvironmentChina
-
Rui WangCompletedRespiratory Distress Syndrome, AdultChina
-
Azienda Ospedaliero Universitaria Maggiore della...CompletedSurgery | Atelectasis | Artificial RespirationItaly
-
University Hospital, MontpellierRecruiting
-
University Hospital, AngersCompleted
-
University of California, San DiegoCompletedAcute Lung Injury | Chronic Thromboembolic Pulmonary HypertensionUnited States
-
Beth Israel Deaconess Medical CenterCompletedAcute Respiratory Distress SyndromeUnited States
-
Hamilton Health Sciences CorporationCanadian Institutes of Health Research (CIHR)CompletedAcute Respiratory Distress SyndromeCanada
-
Tianjin Medical University General HospitalCompleted